title: Successful Desensitization to Cetuximab in a Patient With a Positive Skin Test to Cetuximab and Specific IgE to Alpha-gal.
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: García-Menaya
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Cordobés-Durán
authors.affiliation: Oncology Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Gómez-Ulla
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Zambonino
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: A C
authors.initials: AC
authors.lastname: Mahecha
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: G M
authors.initials: GM
authors.lastname: Chiarella
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Giangrande
authors.affiliation: Allergy Department, Infanta Cristina University Hospital, Badajoz, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Bobadilla-González
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000276:immunology / Q000556:secondary; D000068818:Cetuximab / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods*; D004334:Drug Administration Schedule; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D056144:Pyriform Sinus / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D012882:Skin Tests; D000519:alpha-Galactosidase / Q000097:blood / Q000276:immunology*
chemical_list: D000970:Antineoplastic Agents; D001323:Autoantibodies; D007073:Immunoglobulin E; C576330:GLA protein, human; D000519:alpha-Galactosidase; D000068818:Cetuximab
keywords: Alpha-gal; Cetuximab; Desensitization; Drug hypersensitivity